Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study
- PMID: 35934007
- PMCID: PMC9352274
- DOI: 10.1016/S0140-6736(22)01214-4
Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study
Abstract
Background: Patients often report various symptoms after recovery from acute COVID-19. Previous studies on post-COVID-19 condition have not corrected for the prevalence and severity of these common symptoms before COVID-19 and in populations without SARS-CoV-2 infection. We aimed to analyse the nature, prevalence, and severity of long-term symptoms related to COVID-19, while correcting for symptoms present before SARS-CoV-2 infection and controlling for the symptom dynamics in the population without infection.
Methods: This study is based on data collected within Lifelines, a multidisciplinary, prospective, population-based, observational cohort study examining the health and health-related behaviours of people living in the north of the Netherlands. All Lifelines participants aged 18 years or older received invitations to digital COVID-19 questionnaires. Longitudinal dynamics of 23 somatic symptoms surrounding COVID-19 diagnoses (due to SARS-CoV-2 alpha [B.1.1.7] variant or previous variants) were assessed using 24 repeated measurements between March 31, 2020, and Aug 2, 2021. Participants with COVID-19 (a positive SARS-CoV-2 test or a physician's diagnosis of COVID-19) were matched by age, sex, and time to COVID-19-negative controls. We recorded symptom severity before and after COVID-19 in participants with COVID-19 and compared that with matched controls.
Findings: 76 422 participants (mean age 53·7 years [SD 12·9], 46 329 [60·8%] were female) completed a total of 883 973 questionnaires. Of these, 4231 (5·5%) participants had COVID-19 and were matched to 8462 controls. Persistent symptoms in COVID-19-positive participants at 90-150 days after COVID-19 compared with before COVID-19 and compared with matched controls included chest pain, difficulties with breathing, pain when breathing, painful muscles, ageusia or anosmia, tingling extremities, lump in throat, feeling hot and cold alternately, heavy arms or legs, and general tiredness. In 12·7% of patients, these symptoms could be attributed to COVID-19, as 381 (21·4%) of 1782 COVID-19-positive participants versus 361 (8·7%) of 4130 COVID-19-negative controls had at least one of these core symptoms substantially increased to at least moderate severity at 90-150 days after COVID-19 diagnosis or matched timepoint.
Interpretation: To our knowledge, this is the first study to report the nature and prevalence of post-COVID-19 condition, while correcting for individual symptoms present before COVID-19 and the symptom dynamics in the population without SARS-CoV-2 infection during the pandemic. Further research that distinguishes potential mechanisms driving post-COVID-19-related symptomatology is required.
Funding: ZonMw; Dutch Ministry of Health, Welfare, and Sport; Dutch Ministry of Economic Affairs; University Medical Center Groningen, University of Groningen; Provinces of Drenthe, Friesland, and Groningen.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests We declare no competing interests.
Figures
Comment in
-
Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?Lancet. 2022 Aug 6;400(10350):411-413. doi: 10.1016/S0140-6736(22)01385-X. Lancet. 2022. PMID: 35933996 Free PMC article. No abstract available.
Similar articles
-
Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands.Lancet Rheumatol. 2023 Jul;5(7):e375-e385. doi: 10.1016/S2665-9913(23)00127-3. Epub 2023 May 31. Lancet Rheumatol. 2023. PMID: 37398978 Free PMC article.
-
Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations.Lancet Digit Health. 2023 Jul;5(7):e421-e434. doi: 10.1016/S2589-7500(23)00056-0. Epub 2023 May 16. Lancet Digit Health. 2023. PMID: 37202336 Free PMC article.
-
Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2.Lancet Child Adolesc Health. 2021 Oct;5(10):708-718. doi: 10.1016/S2352-4642(21)00198-X. Epub 2021 Aug 3. Lancet Child Adolesc Health. 2021. PMID: 34358472 Free PMC article.
-
Long COVID prevalence and physiology-centered risks: population-based study in Ukraine.Inflammopharmacology. 2023 Apr;31(2):597-602. doi: 10.1007/s10787-023-01177-1. Epub 2023 Mar 22. Inflammopharmacology. 2023. PMID: 36947300 Free PMC article. Review.
-
Long COVID or Post-COVID-19 Condition: Past, Present and Future Research Directions.Microorganisms. 2023 Dec 11;11(12):2959. doi: 10.3390/microorganisms11122959. Microorganisms. 2023. PMID: 38138102 Free PMC article. Review.
Cited by
-
Long COVID: cognitive, balance, and retina manifestations.Front Med (Lausanne). 2024 Jul 5;11:1399145. doi: 10.3389/fmed.2024.1399145. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39036098 Free PMC article.
-
Assessing the association between antibody status and symptoms of long COVID: A multisite study.PLoS One. 2024 Jun 6;19(6):e0304262. doi: 10.1371/journal.pone.0304262. eCollection 2024. PLoS One. 2024. PMID: 38843198 Free PMC article.
-
The prevalence of long COVID-19 syndrome in hospitalized patients with COVID-19 pneumonia.Infez Med. 2024 Jun 1;32(2):202-212. doi: 10.53854/liim-3202-8. eCollection 2024. Infez Med. 2024. PMID: 38827835 Free PMC article.
-
Casirivimab-imdevimab monoclonal antibody treatment for an immunocompromised patient with persistent SARS-CoV-2 infection: a case report.Commun Med (Lond). 2024 Jun 1;4(1):103. doi: 10.1038/s43856-024-00523-w. Commun Med (Lond). 2024. PMID: 38824216 Free PMC article.
-
Long COVID and cardiovascular disease: a prospective cohort study.Open Heart. 2024 May 27;11(1):e002662. doi: 10.1136/openhrt-2024-002662. Open Heart. 2024. PMID: 38802280 Free PMC article.
References
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous